Mody, Rajal K

2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea

Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., et al. (2017) · Clinical Infectious Diseases

Viral gastroenteritis research and epidemiologySalmonella and Campylobacter epidemiology

Cited by 627

The global burden of fungal diseases

Vallabhaneni, S., Mody, R. K., Walker, T., & Chiller, T. (2016) · Infectious Disease Clinics of North America

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 292

Burden of Candidemia in the United States, 2017

Tsay, S. V., Mu, Y., Williams, S., Epson, E., Nadle, J., Bamberg, W. M., Barter, D. M., Johnston, H. L., Farley, M. M., Harb, S., et al. (2020) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 163

Trends in hospitalizations related to invasive aspergillosis and mucormycosis in the United States, 2000–2013

Vallabhaneni, S., Benedict, K., Derado, G., & Mody, R. K. (2017) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 98

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017

Zhang, A. Y., Shrum, S., Williams, S., Petnic, S., Nadle, J., Johnston, H., Barter, D., Vonbank, B., Bonner, L., Hollick, R., et al. (2020) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 54

Histoplasmosis-associated hospitalizations in the United States, 2001–2012

Benedict, K., Derado, G., & Mody, R. K. (2016) · Open Forum Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 51

Infections in Pediatric Postdiarrheal Hemolytic Uremic Syndrome: Factors Associated With Identifying Shiga Toxin–Producing Escherichia coli

Mody, R. K., Luna-Gierke, R. E., Jones, T. F., Comstock, N., Hurd, S., Scheftel, J., Lathrop, S., Smith, G., Palmer, A., Strockbine, N., et al. (2012) · Archives of Pediatrics & Adolescent Medicine

Escherichia coli research studiesComplement system in diseases

Cited by 42

Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018.

Gold, J. A. W., Seagle, E. E., Nadle, J., Barter, D. M., Czaja, C. A., Johnston, H., Farley, M. M., Thomas, S., Harrison, L. H., Fischer, J., et al. (2021) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 20

Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States

Walker, T. A., Lockhart, S. R., Beekmann, S. E., Polgreen, P. M., Santibanez, S., Mody, R. K., Beer, K. D., Chiller, T. M., & Jackson, B. R. (2018) · Emerging Infectious Diseases

Antifungal resistance and susceptibilityAntibiotic Use and Resistance

Cited by 13

1722. The changing epidemiology of candidemia in the United States: injection drug use as an emerging risk factor for candidemia

Zhang, A. Y., Shrum, S., Williams, S., Vonbank, B., Hillis, S., Barter, D., Petnic, S., Harrison, L. H., Dumyati, G., Phipps, E. C., et al. (2018) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 2